Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease
- PMID: 19428144
- PMCID: PMC2930132
- DOI: 10.1016/j.neurobiolaging.2009.04.008
Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease
Abstract
We examined the relationships between normal aging, Alzheimer's disease (AD), and brain levels of sex steroid hormones in men and women. In postmortem brain tissue from neuropathologically normal, postmenopausal women, we found no age-related changes in brain levels of either androgens or estrogens. In comparing women with and without AD at different ages, brain levels of estrogens and androgens were lower in AD cases aged 80 years and older but not significantly different in the 60-79 year age range. In male brains, we observed that normal aging was associated with significant decreases in androgens but not estrogens. Further, in men aged 60-79 years, brain levels of testosterone but not estrogens were lower in cases with mild neuropathological changes as well as those with advanced AD neuropathology. In male cases over age 80, brain levels hormones did not significantly vary by neuropathological status. To begin investigating the relationships between hormone levels and indices of AD neuropathology, we measured brain levels of soluble β-amyloid (Aβ). In male cases with mild neuropathological changes, we found an inverse relationship between brain levels of testosterone and soluble Aβ. Collectively, these findings demonstrate sex-specific relationships between normal, age-related depletion of androgens and estrogens in men and women, which may be relevant to development of AD.
Copyright © 2009 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Gender, sex steroid hormones, and Alzheimer's disease.Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Horm Behav. 2013. PMID: 22554955 Free PMC article. Review.
-
Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.Brain Res Rev. 2008 Mar;57(2):444-53. doi: 10.1016/j.brainresrev.2007.04.012. Epub 2007 Jul 7. Brain Res Rev. 2008. PMID: 17658612 Free PMC article. Review.
-
Sex and the development of Alzheimer's disease.J Neurosci Res. 2017 Jan 2;95(1-2):671-680. doi: 10.1002/jnr.23827. J Neurosci Res. 2017. PMID: 27870425 Free PMC article. Review.
-
Age-related changes in serum and brain levels of androgens in male Brown Norway rats.Neuroreport. 2009 Nov 25;20(17):1534-7. doi: 10.1097/WNR.0b013e328331f968. Neuroreport. 2009. PMID: 19829160 Free PMC article.
-
Sex hormones, aging, and Alzheimer's disease.Front Biosci (Elite Ed). 2012 Jan 1;4(3):976-97. doi: 10.2741/E434. Front Biosci (Elite Ed). 2012. PMID: 22201929 Free PMC article. Review.
Cited by
-
Gender, sex steroid hormones, and Alzheimer's disease.Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Horm Behav. 2013. PMID: 22554955 Free PMC article. Review.
-
Protective actions of sex steroid hormones in Alzheimer's disease.Front Neuroendocrinol. 2009 Jul;30(2):239-58. doi: 10.1016/j.yfrne.2009.04.015. Epub 2009 May 7. Front Neuroendocrinol. 2009. PMID: 19427328 Free PMC article. Review.
-
Human Cognitive Ability Is Modulated by Aromatase Availability in the Brain in a Sex-Specific Manner.Front Neurosci. 2020 Oct 19;14:565668. doi: 10.3389/fnins.2020.565668. eCollection 2020. Front Neurosci. 2020. PMID: 33192252 Free PMC article.
-
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease.Mol Psychiatry. 2014 Jan;19(1):69-75. doi: 10.1038/mp.2012.147. Epub 2012 Oct 23. Mol Psychiatry. 2014. PMID: 23089633
-
AC-186, a selective nonsteroidal estrogen receptor β agonist, shows gender specific neuroprotection in a Parkinson's disease rat model.ACS Chem Neurosci. 2013 Sep 18;4(9):1249-55. doi: 10.1021/cn400132u. Epub 2013 Aug 6. ACS Chem Neurosci. 2013. PMID: 23898966 Free PMC article.
References
-
- Almeida TA, Papadopoulos N. Progression model of prostate cancer. Methods Mol Biol. 2003;222:211–22. - PubMed
-
- Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999;107 (2):123–36. - PubMed
-
- Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82 (4):239–59. - PubMed
-
- Brinton RD. Impact of estrogen therapy on Alzheimer’s disease: a fork in the road? CNS Drugs. 2004;18 (7):405–22. - PubMed
-
- Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, Pols HA. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol. 1998;147 (9):871–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AG05131/AG/NIA NIH HHS/United States
- F31 NS052143-02/NS/NINDS NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P50 AG005128-21/AG/NIA NIH HHS/United States
- AG23739/AG/NIA NIH HHS/United States
- P50 AG016573-09/AG/NIA NIH HHS/United States
- R01 AG023739/AG/NIA NIH HHS/United States
- NS05214301/NS/NINDS NIH HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- AG16573/AG/NIA NIH HHS/United States
- P50 AG005142-25/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P50 AG005128/AG/NIA NIH HHS/United States
- AG05128/AG/NIA NIH HHS/United States
- R01 AG023739-04/AG/NIA NIH HHS/United States
- P50 AG005131-25/AG/NIA NIH HHS/United States
- AG05142/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical